Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1995-07-05
2000-04-04
Saunders, David
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
4242651, A61K 39018
Patent
active
060458062
ABSTRACT:
The invention is directed to a vaccine comprising Babesia canis antigens from a strain of Babesia canis rossi and another Babesia canis subspecies.
Such a vaccine gives both homologous protection, and heterologous protection to infection with strains other than those of which the antigens have been isolated.
Preferably the antigens are soluble antigens which can be harvested from the supernatant of a culture of Babesia parasites.
REFERENCES:
patent: 4777036 (1988-10-01), Laurent
G. Uilenberg et al., "Three Groups of Babesia Canis Distinguished and a proposal for nomenclature," Biological Abstracts, 88:2:abstract 16375, 1989, Philadelphia PA, USA.
Akzo Nobel N.V.
Blackstone William M.
Saunders David
Sullivan Michael G.
Tung Mary Beth
LandOfFree
Babesia vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Babesia vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Babesia vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-362369